Home Page
EspaƱol

Personal Injury News
FDA News Alerts
  Subscribe to News RSS

Newsletters

Sanders Firm History

Meet the Attorneys

Seminar Registration


   Injury & Accidents

Automobile Accidents
Trip & Fall Accidents
RSD/CRPS
   Defective Drugs

Avandia
Bextra
Celebrex
Chantix
Fosamax
Hydroxycut
Levaquin
Ortho Evra
OxyContin
Prexige
Reglan
Risperdal
Trasylol
VIOXX
Yaz
Vytorin
Zetia
Zicam


   Defective Products

Denture Cream Poisoning

Hernia and Transvaginal Surgical Mesh Patch

Shoulder Pain Pumps

ReliOn Insulin Syringes

Salmonella Contaminated Peanut Butter Recall

Contaminated Syringes
Sierra Pre-Filled Syringes

Johnson & Johnson Duragesic

Actavis Fentanyl Patches

Thoratec HeartMate II

Pacemakers/Defibrillators
Guidant
Medtronic

Yamaha Rhino RTV/ATV


Lead Law

Medical Malpractice

Tile Perfect Stand N' Seal

Legal Malpractice

Police Brutality

Labor Law

Nursing Home Abuse

Social Security

Search

Consultation

Contact Us


Personal Injury Article SAdc4dcb


Sanders Firm - Thursday, January 14, 2010 - Reuters

Suits Allege Harm from Pfizer Quit-Smoking Drug

Three personal injury lawsuits were filed against Pfizer, Inc., on Thur.

NEW YORK, Jan 14 (Reuters) - Three personal injury lawsuits were filed against Pfizer Inc on Thursday, claiming its smoking cessation drug Chantix caused attempted suicides and death.

The lawsuits, filed in New York State Supreme Court in Manhattan, claim that at the time the plaintiffs took Chantix, Pfizer did not tell doctors and patients about dangers it allegedly knew were related to the drug, including depression and thoughts of suicide.

Although Pfizer subsequently added warnings to its package insert, the law firm that filed all three lawsuits alleged the drug's label is still inadequate.

Pfizer introduced Chantix in the United States in 2006, hoping it would become a multibillion-dollar product and revive flagging profits. The drug's sales have fallen off as concerns about side effects increased.

Chantix sales fell 15 percent to $155 million in the third quarter of 2009.

Attorney Marc Grossman alleged in the lawsuits that the company "intentionally, recklessly, and/or negligently concealed, suppressed, omitted, and/or misrepresented the risks, dangers, defects and disadvantages of Chantix."

Grossman is with Sanders Viener Grossman LLP in Mineola, New York.

Two lawsuits claim the plaintiffs tried to kill themselves as a result of using Chantix. The third is a wrongful death lawsuit filed on behalf of Indiana resident Annette Pine, claiming she committed suicide after using Chantix.

The lawsuits seek trials by jury, punitive and compensatory damages, medical and legal expenses, and, in Pine's case, funeral expenses.

Pfizer issued a statement defending the drug, approved in some 86 countries as a smoking cessation aid.

"At all times, Pfizer has clearly communicated important information about the safe use of Chantix, which is available only with a prescription," Pfizer spokeswoman Sally Beatty said in the statement.

"We intend to vigorously defend this medicine," she said, adding that Chantix has helped many smokers to quit.

The lawsuits claim that each of the plaintiffs used the drug properly. They also claim that in each case the plaintiffs and their doctors were "not aware and through diligent efforts were not able to discover the risk of serious injury, and/or depressed mood and/or suicide associated with and/or caused by Chantix." (Reporting by Ransdell Pierson and Bill Berkrot; editing by Carol Bishopric)

 

Sanders, Sanders, Block, Woycik, Viener & Grossman, P.C.. © 2010 • All Rights Reserved • Powered by: OCT